Objective: To evaluate our clinical experience with the use of non-invasive
mechanical ventilation (NIMV) in patients with an acute asthmatic attack.
Design: Seven-year period retrospective observational study.
Setting: General intensive care department (ICU) of a county hospital.
Patients: From 1992 to 1998, we documented clinical data, gas exchange and
outcome of every asthmatic patient admitted to our ICU because of status as
thmaticus (SA) refractory to initial medical therapy.
Interventions: Clinical charts were reviewed and patients were allocated to
two groups according to their suitability as participants in an NIMV trial
. Patients who arrived in respiratory arrest and those who ultimately impro
ved with medical management alone were not considered candidates for NIMV.
For the present analysis, the rest of the patients were considered candidat
es for NIMV, while the decision to start a NIMV trial or to perform endotra
cheal intubation (ETI) remained at the discretion of the attending physicia
n. When patients failed to improve with NIMV, standard mechanical ventilati
on (MV) with ETI was initiated.
Measurements and results: Fifty-eight patients were included in the study.
Twenty-five patients (43 %) were not eligible for NIMV: 11 patients (19 %)
because of respiratory arrest on their arrival at the Emergency Room and 14
patients (24 %) because of improvement with medical management (bronchodil
ators, corticoids and oxygen). The remaining 33 patients were eligible for
NIMV (57 %): 11 patients (33 %) received invasive MV and 22 patients (67 %)
were treated with NIMV. Three NIMV patients(14 %) needed ETI. We compared
data at baseline, 30 min, 2-6 h and 6-12 h after the onset of ventilatory s
upport. Significant differences were observed in arterial blood gases on ad
mission to the Emergency Room between MV and NIMV: PaCO2 (89 +/- 29 mmHg vs
53 +/- 13 mmHg, p < 0.05), pH (7.05 +/- 0.21 vs 7.28 +/- 0.008, p < 0.05)
and HCO3- level (22 +/- 5 mmol/l vs 26 +/- 6 mmol/l,p <0.05). No difference
s were found in the median length of ICU stay (4.5 vs 3 days), median hospi
tal stay (15 vs 12 days) and mortality (0 vs 4%).
Conclusion: Face mask NIMV appears to be a suitable method for improving al
veolar ventilation and can reduce the need for intubation in a selected gro
up of patients with SA.